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TegumentThe herpes simplex virus type 1 (HSV-1) structural tegument proteins pUL36 and pUL37 are essential for
secondary envelopment during the egress of viral particles. For this study, scanning alanine mutagenesis
of HSV-1 pUL37, in combination with yeast two-hybrid, identiﬁed pUL37 residue D631 as a major determi-
nant for binding of pUL36. Further analysis of the binding of this pUL37 mutant to pUL36 by coimmunopre-
cipitation assay conﬁrmed the role of pUL37 D631 in mediating binding of pUL36. A trans-complementation
assay using pUL37 deletion virus FRΔUL37was then carried out, where pUL37wild type or D631Awere pro-
vided in trans. For pUL37 D631A, a signiﬁcant reduction in virus titer was observed compared to that seen
when pUL37 wild type was present. The results presented here underline the crucial role of the pUL36/pUL37
interaction in replication of HSV-1 and indicate a critical role for pUL37 D631 in mediating this interaction.
© 2011 Elsevier Inc. All rights reserved.Introduction
The herpesvirion is composed of four components: a double strand-
ed DNA genome enclosed in an icosahedral capsid, an amorphous pro-
tein layer termed the tegument and a glycoprotein-containing host
cellmembrane-derived envelope (Roizman et al., 2007). Themostwidely
acceptedmodel for herpesviral assembly, based primarily on studieswith
the Alphaherpesvirinae subfamily members herpes simplex virus type 1
(HSV-1) and pseudorabies virus (PrV), is the primary envelopment–
deenvelopment–secondary envelopment pathway (Mettenleiter et al.,
2009). In this model nucleocapsids (capsid containing DNA genome)
are assembled in the nucleus before undergoing primary envelopment
by budding through the inner nuclear membrane into the perinuclear
space. This primary envelope then fuses with the outer nuclear mem-
brane and deenveloped nucleocapsids are deposited in the cytoplasm.
Acquisition of inner tegument onto the nucleocapsid precedes second-
ary envelopment, acquisition of outer tegument and glycoprotein enve-
lope, in or close to the Golgi. Fully assembled virions are ﬁnally released
by exocytosis.
The tegument layer consists of around 20 viral-encoded proteins
(Loret et al., 2008; Mettenleiter, 2004; Roizman et al., 2007) with both
structural and non-structural functions (Kelly et al., 2009). During
entry of a host cell inner tegument proteins pUS3, pUL36 and pUL37
have been shown to remain attached to the capsid while the remainingestmeadMillennium Institute,
9845 9103.
.J. Diefenbach).
rights reserved.tegument and envelope are lost (Antinone and Smith, 2010; Copeland
et al., 2009; Granzow et al., 2005). The inner tegument proteins pUL36
and pUL37, which are conserved across all members of the Herpes-
viridae family, are required for normal maturation of capsids into
enveloped virions. For HSV-1 in cell lines, deletion of the genes
encoding pUL36 or pUL37 blocks further addition of tegument to
capsids in the cytoplasm (Desai, 2000; Desai et al., 2001; Leege et
al., 2009; Roberts et al., 2009). For PrV, while pUL36 is essential for
replication of the virus, pUL37 is not essential for productive infec-
tion in cell lines (Fuchs et al., 2004; Klupp et al., 2002; Leege et al.,
2009). Initial addition of pUL36 to the capsid appears to be depen-
dent on a direct interaction between the C-terminus of pUL36 and
the capsid protein pUL25. This interaction has been identiﬁed in a
number of Alphaherpesvirinae subfamily members including HSV-1
and PrV, using coimmunoprecipitation of transiently expressed pUL25
and pUL36 (Coller et al., 2007; Pasdeloup et al., 2009), and in varicella
zoster virus (VZV), using yeast two-hybrid (Uetz et al., 2006). In the
case of HSV-1, deletion of pUL36 has been shown to block subsequent
addition of pUL37 to nucleocapsids (Ko et al., 2010). Addition of
pUL37 is thought to be through a direct interaction with pUL36 which
is conserved across the Herpesviridae family. The interaction of pUL36
with pUL37 has been identiﬁed using yeast two-hybrid and coimmuno-
precipitation in HSV-1 (Lee et al., 2008; Vittone et al., 2005), PrV (Klupp
et al., 2002), VZV (Stellberger et al., 2010; Uetz et al., 2006), human cy-
tomegalovirus (HCMV) (Bechtel and Shenk, 2002; To et al., 2011) and
Kaposi's sarcoma-associated herpesvirus (KSHV) (Rozen et al., 2008).
Observed localization of HSV-1 pUL37 to the Golgi in infected cells
suggests this is the location where the protein, in complex with pUL36,
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deletion of pUL36 in HSV-1 blocks trafﬁcking of pUL37 to the Golgi in a
capsid-independent manner (Desai et al., 2008), suggests the interac-
tion between these two proteins is key for their incorporation into vi-
rions. Initial addition of pUL36 and pUL37 to HSV-1 nucleocapsids
has been proposed to occur in the nucleus (Bucks et al., 2007).
Other studies on both HSV-1 (Radtke et al., 2010; Trus et al., 2007;
Wolfstein et al., 2006) and PrV (Mohl et al., 2009) indicate addition
of pUL36 to the nucleocapsid occurs only in the cytoplasm.
The 273 kDa pUL36 contains a number of essential and nonessen-
tial domains (Mohl et al., 2010). It is required for intracellular nucle-
ocapsid transport during egress (Luxton et al., 2006; Shanda and
Wilson, 2008) and is a likely receptor for molecular motors (Radtke
et al., 2010; Wolfstein et al., 2006). It also plays a role in release of
viral DNA from the nucleocapsids during entry (Batterson and
Roizman, 1983; Batterson et al., 1983; Delboy et al., 2008; Jovasevic
et al., 2008; Knipe et al., 1979). A conserved deubiquitinating en-
zyme activity has been identiﬁed in the N-terminal region of pUL36
(Kattenhorn et al., 2005; Schlieker et al., 2005), with a nuclear local-
ization signal found adjacent to it (Abaitua and O'Hare, 2008).
The 120 kDa pUL37 has been found to increase the efﬁciency of
transport of nucleocapids to the nucleus, although unlike pUL36, it
is not essential for this process (Krautwald et al., 2009; Luxton et al.,
2006). It has been shown not to have a role in nuclear egress of either
HSV-1 or PrV (Leege et al., 2009) but is required to direct nucleocap-
sids to the site of secondary envelopment at the TGN (Pasdeloup et
al., 2010). It has been found to coelute with the single-stranded
DNA binding protein ICP8 (Shelton et al., 1994), it activates NF-κB sig-
naling via binding to TNF receptor-associated factor 6 (TRAF) (Liu et
al., 2008), and possesses a nuclear export signal (NES) (Watanabe et
al., 2000).
The pUL37-binding region in pUL36 has been previously deﬁned for
both HSV-1 and PrV to HSV-1 residues 512–608 (Klupp et al., 2002;
Mijatov et al., 2007). We subsequently identiﬁed a number of residues
in HSV-1 pUL36 within the described pUL37-binding region, including
F593, E596 and to a lesser extent E580, which mediate interaction
with pUL37 (Mijatov et al., 2007). The pUL37 region which binds
pUL36 has yet to be fully characterized, although a recent study iden-
tiﬁed the carboxy terminal half of pUL37 as important for interac-
tion with pUL36 (Bucks et al., 2011). In this study, we sought to
deﬁne further the pUL36-binding region within HSV-1 pUL37. Single
alanine substitutions were engineered into pUL37 and tested for bind-
ing against pUL36 using a yeast two-hybrid assay, allowing identiﬁca-
tion of a key conserved amino acid residue, D631, which is essential
for binding to pUL36 in vitro. Further analysis by coimmunoprecipita-
tion assay conﬁrmed the role of pUL37 D631 in mediating binding of
these two inner tegument proteins. When a trans-complementation
assay was carried out, where wild type or mutant forms of pUL37
were tested for their ability to complement the pUL37 deletion virus
FRΔUL37, mutation of the pUL37 D631 residue was found to signiﬁ-
cantly reduce production of infectious virus. The results presented
here offer further insight into the highly conserved interaction
between inner tegument proteins pUL36 and pUL37 and provide
details of a single amino acid residue of pUL37 which plays a key
role in mediating this interaction.
Results
Alanine-scanning mutagenesis of pUL37
A preliminary attempt to deﬁne a pUL36-binding domain in pUL37
using a series of pUL37 truncations in the yeast two-hybrid assay was
unsuccessful (not shown). This is in contrast to a recent study which
used a coimmunoprecipitation assay rather than a yeast two-hybrid
approach (Bucks et al., 2011). We then undertook scanning alanine
substitution of conserved HSV-1 pUL37 residues. Alignment of HSV-1pUL37 with sequences from several other members of the Alphaherpes-
virinae subfamily identiﬁed a total of 110 conserved residues located
throughout pUL37 (Fig. 1). As it was not feasible to mutate all residues,
a total of seventeen of these pUL37 residueswere chosen, predominantly
based on charge, and targeted for site-directed mutagenesis in the hope
of identifying key residue(s) which mediate an interaction with pUL36.
The current study was initiated prior to the recent report identifying a
minimal pUL36 binding domain in HSV-1 pUL37 corresponding to resi-
dues 568–1123 (Bucks et al., 2011). The pUL37 substitutions to alanine
were generated in a background of Target/pUL37 full-length and
assessed for their ability to bind Bait/pUL36(1–767) using the yeast
two-hybrid assay (Fig. 2A). A liquid β-galactosidase assay indicated
that the most signiﬁcant reduction in binding of pUL36, in the range 1–
26% of wild type, was observed for the substitutions W175A, F420A,
Y480A and D631A (Fig. 2A). Of these, only the W175A mutation maps
to a proposed pUL37 self-association domain while D631Amaps to a re-
cently identiﬁed pUL36 binding domain (Bucks et al., 2011). Intermedi-
ate reductions, in the range 43–74% of wild type, were observed for
E108A, R117A, R265A, D274A, R530A, R553A, R657A and R671A
(Fig. 2A). Substitutions which had the least effect, in the range 79–
113%, of wild type included R158A, Q232A, R348A, D658A and D1038A
(Fig. 2A). For each Target/pUL37 mutation no autoactivation was ob-
served when tested against Bait/no insert (not shown). Each of the Tar-
get/pUL37 alanine substitutions was also conﬁrmed to be expressed in
yeast at equivalent levels to wild type (Fig. 2B).
Coimmunoprecipitation assay
The four pUL37 mutants (W175A, F420A, Y480A and D631A) which
exhibited the most signiﬁcant reduction in binding to pUL36 by yeast
two-hybrid analysis were further analyzed by coimmunoprecipita-
tion assay. Both wild type pUL37 and pUL37 alanine mutant coding
sequences were cloned into the pCMVmyc mammalian expression
vector. The coding sequence of a further pUL37 mutant (R158A) which
did not affect binding of pUL37 to pUL36 according to yeast two-hybrid
analysis, was also cloned into the pCMVmyc vector to serve as a control
to ensure that any effect observed for the alanine mutants was speciﬁc
to those particular amino acid changes. The region of pUL36 encoding
the pUL37 binding site (fragment N2; amino acids 512–767) was cloned
into pEGFP-N1 vector and expressed as a GFP fusion protein. A region of
pUL36 adjacent to the pUL37 binding site (fragment N1; amino acids
317–511) was also expressed as a GFP fusion protein, and served as a
negative control.
Hela cells were cotransfected with expression constructs en-
coding pUL36N1-GFP or pUL36N2-GFP and each of the myc-pUL37
expression constructs encoding myc-pUL37WT, myc-pUL37R158A,
myc-pUL37W175A, myc-pUL37F420A, myc-pUL37Y480A, or myc-
pUL37D631A. Cell lysates were harvested at 24 h post transfection
and coimmunoprecipitation with anti-myc antibody was carried out.
Western blot of input lysates conﬁrmed expression of myc and
GFP fusion proteins (Fig. 3A). Analysis of coimmunoprecipitation
samples by western blot using an anti-GFP antibody revealed that
pUL36N1-GFP was not precipitated by any of the myc-tagged pUL37
proteins (Fig. 3B). In samples coexpressing pUL36N2-GFP and myc-
tagged pUL37 proteins, pUL36N2-GFP precipitated with myc-pUL37WT
and myc-pUL37R158A, as expected. Despite lower levels of myc-
pUL37W175A, myc-pUL37F420A and myc-pUL37Y480A in the lysates
(Fig. 3A) and coimmunoprecipitation samples (Fig. 3B), each of these
mutants also precipitated pUL36N2-GFP, albeit at a correspondingly
lower level compared to myc-pUL37WT (Fig. 3B). The level of myc-
pUL37D631A detected in the coimmunoprecipitation sample was simi-
lar to that of myc-pUL37WT (1.4 fold that of the wild type) (Fig. 3B),
however the amount of pUL36N2-GFP that precipitated with myc-
pUL37D631A was 16-fold less than with myc-pUL37WT (Fig. 3B). A 7
fold lower level of pUL36N2-GFP expression was detected in samples
coexpressing myc-pUL37D631A compared to those coexpressing myc-
Fig. 1. Alignment of HSV-1 pUL37 with homologues of pUL37 from the Alphaherpsvirinae subfamily. Family members shown include HSV-1, HSV-2, Bovine herpesvirus 1 (BHV-1),
Bovine herpesvirus 5 (BHV-5), Pseudorabies virus (PrV), Equine herpesvirus 1 (EHV-1), Equine herpesvirus 4 (EHV-4) and Varicella-zoster virus (VZV). The encoded pUL37
sequences were obtained from the following GenBank herpesviral genome sequence accession numbers: HSV-1 [X14112]; HSV-2 [Z86099]; BHV-1 [AJ004801]; BHV-5
[AY261359]; PrV [BK001744]; EHV-1 [AY665713]; EHV-4 [AF030027]; and VZV [X04370]. Clustal W alignments were generated using Lasergene version 8.02 MegAlign software
fromDNASTAR. The consensus sequence is shown above the alignments. Dashes indicates gaps introduced tomaximize alignment while an asterisk indicates a residue that wasmutated
in this study. Also indicated with a box are the leucine rich region (LRR)/nuclear export signal (NES) and the TRAF6 binding domain (DB) consensus sequence.
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Fig. 2. Binding properties of single alanine substitutions of conserved pUL37 residues. (A) Summary of LexA yeast two-hybrid liquid β-galactosidase assay for the interaction of
Bait/pUL36(1–767) with Target/pUL37 full-length wild type (WT) or alanine substitution mutant. Negative control consisted of Bait/pUL36(1–767) and Target/no insert. Num-
bers above each histogram represent β-galactosidase activity relative to Target/pUL37 WT binding to Bait/pUL36(1–767). (B) Expression of Target/pUL37 full-length mutants
with respect to Target/pUL37 full-length WT in yeast. Protein complexes were separated by SDS-PAGE (4–20%) and immunoblotted with mouse anti-HA monoclonal antibody.
Each panel represents a separate evaluation. Error bars represent the standard deviation of β-galactosidase activity determined in triplicate.
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experiments and may suggest a role for pUL37 binding in stabilization
of pUL36N2-GFP. Despite this difference in expression, however, the
16 fold lower level of pUL36N2-GFP which precipitated with myc-
pUL37D631A compared to myc-pUL37WT suggests that the presence
of the D631A amino acid change in pUL37 is inhibiting binding to this
region of pUL36. Therefore, in our follow-up from the initial yeast
two-hybrid screen (Fig. 2) only D631A could be conﬁrmed as a resi-
due which contributes to the interaction of pUL37 with pUL36. As
such the remainder of this study has focused on this residue.
Since this initial coimmunoprecipitation assay only employed
the portion of pUL36 containing the pUL37 binding site, we wished
to investigate the affect of the D631A mutation on binding of pUL37
to full-length pUL36 in the context of a more biologically relevant
virus infection. Hela cells were transfected with myc-pUL37WT,
myc-pUL37R158A, myc-pUL37D631A, expressing vectors or mock
transfected. At 24 h post transfection cells were mock-infected or
infected with HSV-1 strain 17 at a MOI of 5 pfu/ml as a source of
full-length pUL36. Cell lysates were harvested at 26 h p.i. Similar
levels of input pUL36 were detected for each virus-infected sample
(Fig. 4). A coimmunoprecipitation assay using anti-myc antibody
was carried out. Both myc-pUL37WT and myc-pUL37R158A coim-
munoprecipitated full-length viral pUL36 (Fig. 4). However, myc-
pUL37D631A did not precipitate full-length viral pUL36 (Fig. 4)
conﬁrming that this mutation can disrupt interaction of pUL37 and
full-length pUL36 in the presence of the full complement of viral pro-
teins. Full-length pUL36 was not detected in coimmunoprecipitation
samples mock transfected and then infected with HSV-1 strain 17
(Fig. 4). The amount of pUL36 detected in coimmunoprecipitation sam-
pleswas low compared to the level detected in the input lysates (Fig. 4).
This may be explained by the fact that competition would have
occurred between viral pUL37 and myc-tagged pUL37 for binding
to available pUL36. To avoid this, an initial coimmunoprecipitation
assaywas performed using the pUL37 deletion virus FRΔUL37. However,
the levels of pUL36 detected in the input lysates were not equivalent
over all samples (see Fig. 5) so any difference in the levels ofprecipitation of pUL36 could not be relied upon to accurately represent
the effect of the D631A mutation in blocking this interaction. Neverthe-
less, the pUL37 D631Amutation clearly causes a reduction in binding to
full-length pUL36.
Trans-complementation assay
Two independent coimmunoprecipitation assays conﬁrmed that
the amino acid change D631A in pUL37 inhibited binding to pUL36.
To investigate the effect of this single amino acid mutation on replica-
tion of the virus, we carried out a trans-complementation assay using
pUL37 deletion virus FRΔUL37. Hela cells were transfected with myc-
pUL37WT, myc-pUL37D631A, myc-pUL37R158A expressing plasmids,
or mock transfected. Cells were also transfected with a vector expres-
sing myc-tagged dynein light chain subunit roadblock (myc-DYNLRb)
as a negative control. At 24 h post transfection, cells were infected
with FRΔUL37 at an MOI of 5 pfu/cell. Control wells were infected
with HSV-1 strain 17, also at an MOI of 5. An initial examination of
protein expression was carried out to ensure myc-tagged proteins
were expressed to equivalent levels (Fig. 5). Cell lysates were har-
vested at 48 h p.i. and western blot analysis was carried out. Initially
samples were assayed for expression of myc-pUL37 proteins using
an anti-myc antibody. Equivalent levels of myc-tagged pUL37 pro-
teins were detected in each sample (Fig. 5A). Expression of pUL37
was also detected using an anti-pUL37 antibody highlighting that
no pUL37 protein was produced by the FRΔUL37 virus (Fig. 5B). A
number of other viral proteins alongwith the cellular protein tubulin
(Fig. 5F) were assayed to ensure they were detected at equivalent
levels in all samples. The major capsid protein pUL19 (VP5) and the
major tegument protein pUL48 (VP16) were both detected in each
virus-infected sample at similar levels (Figs. 5C and D). However,
when we assayed for the inner tegument protein pUL36 we found
that levels of the protein detected differed between samples. Similar
levels of pUL36 were detected in myc-pUL37WT/FRΔUL37 and myc-
pUL37R158A/FRΔUL37. However, the levels of pUL36 detected in
myc-pUL37D631A/FRΔUL37 samples were reduced (Fig. 5E). This
Fig. 3. Coimmunoprecipitation of pUL36-GFP with myc-pUL37WT and alanine substi-
tution mutants. (A) Expression of myc-pUL37 proteins and pUL36-GFP proteins. Hela
cells were transfected with the indicated constructs and harvested at 24 h p.i. Cell lysates
were analyzed by western blot using rabbit anti-myc antibody (top panel) and rabbit
anti-GFP antibody (bottom panel). (B) Coimmunoprecipitation of pUL36-GFP with
myc-pUL37WT and alanine substitution mutants. Anti-mouse IgG whole molecule
agarose was incubated with mouse anti-myc monoclonal antibody before incubation
with cell lysates. Immunoprecipitated proteins were analyzed by SDS-PAGE and western
blotting using rabbit anti-myc antibody (top panel) and rabbit anti-GFP antibody (bottom
panel). N1, amino residues 317–511; N2, amino acid residues 512–767.
Fig. 4. Coimmunoprecipitation of full-length viral pUL36 with myc-pUL37WT and ala-
nine substitution mutants. Hela cells were transfected with the indicated constructs
before infections with mock or HSV-1 Strain 17 at 24 h post transfection. Cell lysates
were harvested at 26 h p.i. and analyzed by western blot. Expression of input full-
length pUL36 was determined with rabbit anti-pUL36 antibody (top panel). Coimmu-
noprecipitation of full-length pUL36 with myc-pUL37WT and alanine substitution mu-
tants was then performed. Cell lysates were incubated with mouse anti-myc antibody
before incubation with anti-mouse IgG whole molecule agarose beads. Immunopreci-
pitated proteins were analyzed by SDS-PAGE and western blot using rabbit anti-
pUL36 antibody (middle panel) and rabbit anti-myc antibody (bottom panel). The
upper pUL37 bands in each case are migrating at the same mobility i.e. ~125 kDa
while the variation in the presence of lower molecular weight pUL37 fragments is
due to variable proteolysis of pUL37 (even in the presence of protease inhibitors).
MI, mock infected; I, infected.
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experiments. The reduction in levels of pUL36 detection for myc-
pUL37D631A/FRΔUL37 and FRΔUL37 samples ranged from 45 to
70% of myc-pUL37WT/FRΔUL37 levels at 48 h p.i. (Fig. 5). This sug-
gests that there is a reduction in levels of pUL36 protein when the in-
teraction of pUL36/pUL37 does not occur, similar to the effect seen
for cells coexpressing myc-pUL37D631A/pUL36N2-GFP (Fig. 3A).
While it is unlikely that expression of pUL36 is downregulated in
these cells, it may be that the interaction of pUL36 with pUL37 some-
how plays a role in affecting the stability of pUL36 and in the absence
of this interaction the protein is more readily degraded. Further
investigation is needed to explain this observation fully.
At 24 and 48 h p.i., cells and media were harvested and the
amount of virus produced was determined by plaque assay titration
and represented as plaque forming units per ml (pfu/ml) (Fig. 6).
Transfection of cells with myc-pUL37WT before infection with
FRΔUL37 resulted in a partial recovery of viral titers compared to
cells whichwere only infectedwith FRΔUL37 (Fig. 6). Although titers
from HSV-1 strain 17-infected cells were still signiﬁcantly higher
than myc-pUL37WT/FRΔUL37 cells (Fig. 6), this partial recoverydemonstrated the ability of myc-pUL37WT to complement the
FRΔUL37 replication defect to some degree. While HSV-1 strain 17-
infected cells produced mean titers of almost 8×106 pfu/ml at 24 h
p.i. and over 1×107 pfu/ml at 48 h p.i., myc-pUL37/FRΔUL37 sam-
ples produced mean titers of 1.8×106 pfu/ml and 4.4×106 pfu/ml
at 24 and 48 h p.i., respectively (Fig. 6). Titers of virus produced
from cells transfected with myc-pUL37R158A and infected with
FRΔUL37 recovered to a similar level as those seen for myc-
pUL37WT/FRΔUL37 samples at 24 h p.i. (Fig. 6A). However, at 48 h
p.i. mycR158A/FRΔUL37 titers failed to reach those seen for myc-
pUL37WT/FRΔUL37, although they still recovered somewhat com-
pared to titers from cells which were only infected with FRΔUL37
(Fig. 6B). The inability of myc-pUL37R158A to complement the
FRΔUL37 replication defect to the same extent as myc-pUL37WT at
this timepoint may reﬂect some adverse effect on assembly of the
virus due to the R158A mutation. Although this amino acid change
does not affect the interaction between pUL36 and pUL37 it may
still affect some aspect of pUL37's role in assembly. Further investi-
gation is required to identify what this may be. Transfection of
myc-pUL37D631A before FRΔUL37 infection resulted in signiﬁcantly
less virus production than for cells transfected with myc-pUL37WT
before infection with the pUL37 deletion mutant virus (Fig. 6).
Mean titers for myc-pUL37D631A/FRΔUL37 samples reached only
3.1×105 pfu/ml at 24 h p.i. and 5.1×105 pfu/ml at 48 h p.i. These
were similar to levels seen for cells transfected with myc-DNYLRb
before infection with FRΔUL37 and cells which were only infected
with FRΔUL37 (Fig. 6). The similarity of titers detected in myc-
pUL37D631A/FRΔUL37 samples to those of both negative controls
suggests a defect in replication due to inhibition of the pUL36/
pUL37 interaction. Whether reductions in viral titer are due directly
to this inhibition or to the observed reduced expression levels of
pUL36 (Fig. 5E) requires further investigation. As well as further
underlining the importance of the pUL36/pUL37 interaction in as-
sembly of HSV-1, these results along with those of the coimmuno-
precipitation assay using whole virus, suggest that the role of the
D631 residue in this interaction, which was initially identiﬁed by
yeast two-hybrid, is relevant in the context of the viral lifecycle.
Fig. 5. Protein expression analysis of trans-complementation assay samples. Hela cells
were transfected with myc-pUL37WT, alanine susbstitution mutants, myc-DYNLRb or
mock transfected before infection with FRΔUL37 or HSV-1 Strain 17 at 24 h post trans-
fection. Infection was at an MOI of 5 pfu/ml. Cell lysates were harvested 48 h p.i. and
analyzed by SDS-PAGE and western blot using the following antibodies: mouse anti-
myc (A), rabbit anti-pUL37 (B), mouse anti-pUL19 (C), rabbit anti-pUL48 (D), rabbit
anti-pUL36 (E) and mouse anti-tubulin (F).
Fig. 6. Trans-complementation assay to assess the ability of myc-pUL37WT or myc-
tagged alanine substitution mutants to complement FRΔUL37 and rescue virus produc-
tion. Hela cells were transfected with myc-pUL37WT, alanine susbstitution mutants,
myc-DYNLRb or mock transfected before infection with FRΔUL37 or HSV-1 Strain 17
at 24 h post transfection. Infection was at an MOI of 5 pfu/ml. Cells and media were
collected at 24 h p.i. (A) and 48 h p.i. (B) and subjected to three rounds of freeze/
thaw to release intracellular virus. The amount of infectious virus in each sample
was determined by plaque assay titration. These data represent results of two inde-
pendent experiments.
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Extensive studies have been conducted on the identiﬁcation of func-
tional domains within the essential conserved herpesviral tegument
protein pUL36 along with validation of their role in viral replication
(Bottcher et al., 2007; Mohl et al., 2010). These studies, primarily on
HSV-1 and PrV, have identiﬁed deubiquitinating enzymatic activity
in the N-terminal 500 amino acids of pUL36 (Bolstad et al., 2011;
Bottcher et al., 2007, 2008; Kattenhorn et al., 2005), an adjacent
binding domain for the tegument protein pUL37 (Klupp et al., 2002;Mijatov et al., 2007; Vittone et al., 2005) and a capsid binding domain
in the extreme C-terminal region which interacts with the capsid pro-
tein pUL25 (Coller et al., 2007; Pasdeloup et al., 2009). In addition, a
709 amino acid internal region in the C-terminal half of PrV-1 pUL36
has been shown to be nonessential for viral replication (Bottcher et
al., 2006). In contrast, little is known regarding the nature of functional
domainswithin pUL37 and the precise role of pUL37 in viral replication.
In addition to binding to pUL36, HSV-1 pUL37 has been reported to
copurify with HSV-1 DNA-binding protein ICP8 (Albright and Jenkins,
1993; Shelton et al., 1994) and our laboratory, using the yeast two-
hybrid assay, has also identiﬁed self-association of HSV-1 pUL37, as
well as interactions with the capsid protein pUL35, and the tegument
protein pUL46 (Lee et al., 2008; Vittone et al., 2005). Furthermore,
pUL37 has a functional nuclear export signal in the form of a leucine
rich region, residues 263–273 (Fig. 1), as shown for HSV-2 (Watanabe
314 B.J. Kelly et al. / Virology 422 (2012) 308–316et al., 2000). More recently the C-terminus of pUL37 has been identiﬁed
as containing a TNF receptor-associated factor 6 (TRAF6) binding do-
main consensus sequence, residues 1099–1104 (Fig. 1). This region of
HSV-1 pUL37 interacts with TRAF6 with resulting activation of NF-κB
signalling pathways (Liu et al., 2008). To date, the exact relevance of
these ﬁndings for pUL37, if any, has not been determined in the con-
text of viral replication.
As a prerequisite to deﬁning the role of the HSV-1 pUL36/pUL37
interaction in the context of viral replication we ﬁrst sought to eluci-
date the nature of binding of pUL37 to its known binding partner
pUL36. We have previously deﬁned the minimal pUL37 binding site
in HSV-1 pUL36 (Mijatov et al., 2007) and in this study sought to
deﬁne the pUL36 binding site in HSV-1 pUL37. Initial attempts to
deﬁne a minimal binding domain in pUL37 which interacts with
pUL36 were not successful. This suggests that unlike the previously
identiﬁed pUL37 binding domain in pUL36 (Mijatov et al., 2007) or
the TRAF6 binding domain in pUL37 (Liu et al., 2008) which both
map to a linear epitope, the nature of binding of pUL37 to both
pUL36 and itself depends on a conformational epitope. A recent
study by Bucks et al. also suggested that conformation of pUL37
may be sensitive to mutation, however, they did succeed in deter-
mining that residues within the C-terminal half of pUL37 (residues
568–1123) are important for interaction with pUL36 (Bucks et al.,
2011). Our initial assessment of a subset of conservedHSV-1pUL37 res-
idues by yeast two-hybrid identiﬁed D631 within this C terminal half
of pUL37 as a major determinant for binding of pUL36. Furthermore,
this residue is in a region (568–809) which has been suggested to be
integral for interaction with pUL36 but not for self-association with
pUL37 (Bucks et al., 2011). We further conﬁrmed the importance of
D631 in this interaction by two independent coimmunoprecipitation
assays. The ﬁrst used pUL36(512–767) expressed as an GFP fusion
protein and conﬁrmed that when the D631 residue was mutated to
alanine, myc-pUL37 binding to this fragment of pUL36 containing
the pUL37 binding site was reduced 16-fold. The strong interaction
detected between wild type myc-pUL37 and pUL36(512–767)-GFP
conﬁrmed the interaction between pUL36 and pUL37 detected by
yeast two-hybrid in this study and coimmunoprecipitation in an inde-
pendent study (Bucks et al., 2011) and illustrates that this interaction
is independent of other viral proteins. The second coimmunoprecipita-
tion assay that was performed used infection with HSV-1 strain 17 as a
source of full-length pUL36. This assay conﬁrmed that pUL36 and
pUL37 interact in the context of a viral infection as well as conﬁrming
that the amino acid change D631A inhibits this interaction even in
the presence of full-length pUL36 and the full complement of viral pro-
teins. This ﬁnding emphasizes the biological relevance of this amino
acid in the interaction between pUL37 and pUL36 and this was further
underlined by a trans-complementation assay which found that myc-
pUL37D631A was incapable of rescuing viral titers to levels seen
when myc-pUL37WT was provided in trans. The precise nature of the
role of D631 in binding of pUL37 to pUL36 remains to be determined.
Reduced levels of both pUL36N2-GFP and full-length pUL36
were detected when pUL37 was absent or when binding of pUL37
to pUL36 was disrupted by the D631A mutation. This suggests a
role for the pUL36/pUL37 interaction in stabilization of pUL36. This is
supported by a recent study inwhich a possible target for ubiquitination
was identiﬁed within residues 498 to 703 of pUL36 (Bolstad et al.,
2011), a region encompassing the pUL36N2 fragment. The authors
also observed that while expression of full-length pUL36 containing
an inactive ubiquitin speciﬁc protease domain (USP) was unstable
when expressed in isolation, virus infection stabilized the protein,
leading to the suggestion that binding of other viral proteins to
pUL36 may result in a change in folding or a direct masking of ubi-
quitination sites. Taken together with our ﬁndings here, pUL37 may
likely play such a role. It has previously been reported that pUL36
is required for trafﬁcking of pUL37 to the Golgi (Desai et al., 2008),
suggesting that this interaction is required for incorporation of thesetwo inner tegument proteins into the virion. Further work needs to
be carried out to determine whether stabilization of pUL36 is an ad-
ditional function of the pUL36/pUL37 interaction.
In summary, this study offers further insight into the interaction
between inner tegument proteins pUL36 and pUL37 and provides
further evidence of the importance of this interaction for replication
of HSV-1.
Materials and methods
Cell culture and viruses
Vero cells and Hela cells were maintained in Dulbecco's modiﬁed
Eagle medium (DMEM) (Invitrogen) supplemented with 10% (v/v)
fetal bovine serum (FBS) (JRH Bioscience). The pUL37 complementing
(80C02) cell line (provided by F. Rixon, MRC Virology unit, University
of Glasgow, Glasgow, United Kingdom; (Roberts et al., 2009)) was
maintained in DMEM supplemented with 10% FBS, 1× nonessential
amino acids (NEAAs) (Invitrogen), and 0.5 mg/ml of Geneticin (Invitro-
gen). The HSV-1 strain 17 was propagated in Vero cells. The FRΔUL37
mutant virus (provided by F. Rixon; (Roberts et al., 2009)) was propa-
gated in 80C02 cells. For virus infections, virus inocula were prepared
in DMEM supplemented with 2% FBS and 1% penicillin and streptomy-
cin. Infections were established by inoculating cells in monolayers
with virus for 1 h at 37 °C. After this time fresh DMEM, supplemented
as for inocula, was added.
Expression constructs
TheHSV-1 full-length UL37ORF encoding amino acids 1–1123 cloned
into displayTarget or pCMVmyc have been previously described (Vittone
et al., 2005). In addition, pUL37 was ampliﬁed from the displayTarget
pUL37 construct and inserted into the EcoRI/BamHI site of pEGFP-
N1 (Clontech). The pUL36 fragments corresponding to amino acids
317–511 and 512–767 were ampliﬁed from previously described
displayBait pUL36(1–767) (Vittone et al., 2005) and inserted into
the EcoRI/SalI site of pEGFP-N1. The expression construct myc-
DYNLRb was kindly provided by K. Pﬁster (Department of Cell Biolo-
gy, University of Virginia, Charlottesville, Virginia) (Lo et al., 2007).
Mutations in the context of full-length pUL37 were made using the
QuikChange® II XL Site-Directed Mutagenesis Kit (Stratagene). Oli-
gonucleotide primer pairs for introducing alanine substitutions
were designed using the web-based program primerX (http://
bioinformatics.org/primerx). All generated inserts in each expres-
sion construct were fully sequenced.
Yeast two-hybrid assay
The use of the LexA-based yeast two-hybrid assay including pro-
tocols for qualitative plate-based assessment of protein-protein in-
teractions, quantiﬁcation of each positive interaction using a liquid
β-galactosidase assay and determination of protein expression in
yeast were as previously described (Vittone et al., 2005).
Coimmunoprecipitation assay
Hela cells were grown to 80% conﬂuency in 6 well plates at 37 °C
(5% CO2) in Dulbecco's modiﬁed Eagle medium (Gibco) supplemen-
ted with 9% (v/v) fetal calf serum (JRH Bioscience). Cells were tran-
siently transfected using Lipofectamine 2000 transfection reagent
(Invitrogen). Duplicate wells were prepared in each case. For myc/
GFP cotransfections, cells were harvested at 24 h post transfection.
Mouse anti-IgG (whole molecule) agarose (Sigma) was incubated
overnight with 5 μg of mouse anti-myc antibody (Santa Cruz) at
4 °C with gentle rotation. The following day, agarose beads were
washed ﬁve times with PBS 0.1% (v/v) Triton X-100. Cell lysates
315B.J. Kelly et al. / Virology 422 (2012) 308–316were added to the agarose beads and incubated for 3 h at 4 °C with
gentle rotation. Agarose beads were harvested by spinning at 500 g
for 5 min and then washed 5 times with 500 μl of wash buffer (PBS
containing 0.1% (v/v) Triton X-100). Protein complexes were then
eluted into 50 μl of 2× reducing SDS-PAGE sample buffer (Sigma)
by heating at 95 °C for 5 min.
For transfection/infection experiments, cells were infected with
HSV-1 Strain 17 at 24 h post transfection at an MOI of 5 pfu/ml and
then incubated at 37 °C for a further 26 h. At time of harvest, cells
were washed twice with PBS before the addition of 250 μl per well
of lysis buffer (PBS, 0.1% (v/v) Triton X-100, 1× mammalian protease
inhibitors (MPI; Sigma)) and incubation at 4 °C for 10 min with gen-
tle rocking. After incubation, cells were scraped into lysis buffer and
transferred to prechilled eppendorf tubes. Cells were lysed by incuba-
tion on ice for 30 min before pelleting of cell debris for 20 min at 4 °C.
Analysis of protein complexes
Proteins were separated by SDS-PAGE and immunoblots were
processed as previously described (Vittone et al., 2005). For immu-
noblots of pUL36, 6% SDS-PAGE was used. Detection was performed
with an Odyssey Infrared Imaging system (Licor-Biosciences). Pri-
mary antibodies used included mouse monoclonals against LexA
(1:500 dilution), c-myc (1:100 dilution; all from Santa Cruz), tubulin
(1:2000 dilution; Invitrogen) and HSV-1 pUL19 (DM165) (1:2500
dilution; provided by F. Rixon; (McClelland et al., 2002)); and rabbit
polyclonals against LexA (1:500 dilution; Sigma), HSV-1 pUL48 (1:2500
dilution; Abcam), HSV-1 pUL36 (1:1000 dilution) and HSV-1 pUL37
(1:15,000 dilution) (both kindly provided by T. Mettenleiter, Institute of
Molecular Biology, Friedrich-Loefﬂer-Institut, Greifswald-Insel Riems,
Germany; (Leege et al., 2009)). Secondary antibodies for the Odyssey
system included goat anti-mouse IRDye 680-conjugated IgG (1:5000
dilution; Licor) and goat anti-rabbit IRDye 800-conjugated IgG
(1:5000 dilution; Licor).
Trans-complementation assay
Hela cells were grown in 6 well plates until 80% conﬂuent before
transfection using lipofectamine 2000 (Invitrogen). At 24 h post trans-
fection, cells were infected at an MOI of 5 pfu/cell with FRΔUL37. At
24 and 48 h p.i. cells and media were harvested. Cells were subjected
to three rounds of freeze/thaw to release intracellular virus. Cell debris
was pelleted by centrifugation at 3000 g for 5 min. Supernatant was
stored at−80 °Cbefore titration by plaque assay as previously described
(Ko et al., 2010) on pUL37 complementing 80C02 cells. Duplicate wells
were used for titration of virus at each timepoint, while a third well
was harvested for analysis of protein expression as described earlier.
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